• OPEN AN ACCOUNT
Indian Indices
Nifty
24,793.25 -18.80
(-0.08%)
Sensex
82,422.54 1,060.67
( 1.30%)
Bank Nifty
55,577.45 -251.30
( -0.45%)
Nifty IT
38,664.95 -365.95
( -0.94%)
Global Indices
Nasdaq
42,197.27 -39.54
(-0.09%)
Dow Jones
6,001.75 -1.97
(-0.03%)
Hang Seng
38,498.24 9.90
(0.03%)
Nikkei 225
8,791.80 -51.67
(-0.58%)
Forex
USD-INR
86.44 0.19
(0.22%)
EUR-INR
99.39 -0.08
(-0.08%)
GBP-INR
116.19 -0.40
(-0.35%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Ashok Leyland Ltd
Industry :  Automobiles - LCVs / HCVs
BSE Code
ISIN Demat
Book Value()
500477
INE208A01029
39.2259006
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASHOKLEY
21.12
68347.67
EPS(TTM)
Face Value()
Div & Yield %
11.02
1
2.69
 

Sun Pharma updates on US FDA inspection
Jun 14,2025
Sun Pharmaceutical Industries has informed that the US FDA conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited's Halol facility (Gujarat, India) from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483, with 8 observations.